
Pharma Pulse 11/28/24: Nov. 27 Passed—What Does That Mean for DSCSA? & more
The latest news for pharma industry insiders.
Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.
Poor balance and coordination are prominent features of Friedreich’s ataxia (FRDA). Czech researchers found that neuropsychiatric symptoms are also common among patients with FRDA.
Butterball started out with a boring, standard software implementation—and ended with the creation of a Thanksgiving turkey that you do not need to thaw.
The "Enterprise Tech Ecosystem Series: AbbVie Inc. - 2024" company profile has been added to ResearchAndMarkets.com's offering.
The report provides insights into AbbVie's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
Happy Thanksgiving to all of our readers, listeners, experts, and clients! We're so thankful for all of the voices that help Pharmaceutical Executive be an authority in the pharma industry.
Looking forward to finishing out 2024 strong, and preparing to hit the ground running in 2025!
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor 
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

